| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |